Access cutting-edge venous thromboembolism treatment through this clinical trial at a research site in Milwaukee. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Milwaukee location
Preparing your pre-screening questions…
Access venous thromboembolism specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related venous thromboembolism treatment provided free
Check if you qualify for this venous thromboembolism clinical trial in Milwaukee, WI
No-Cost Study Care
Local to Milwaukee
Convenient for WI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, particularly in those subgroups of patients who are usually not recruited in randomized clinical trials (pregnant women, elderly patients, disseminated cancer, severe renal insufficiency, patients with contraindications to anticoagulation therapy, extreme body weight, etc), with the purpose of decreasing mortality, frequency of thromboembolic recurrences as well as bleeding complications and arterial events. As an additional objective RIETE is also aimed to create predictive scores that help physicians to better identify patients with high risk of presenting some of these complications. The primary parameters recorded by the registry comprise details of each patient's clinical status, including any coexisting or underlying conditions, and the type, dose, duration and outcome (during the first 3 months of therapy) of antithrombotic treatment. Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.
Sponsor: Manuel Monreal
Yes, this clinical trial (NCT02832245) has an active research site in Milwaukee, WI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for venous thromboembolism treatment options in Milwaukee, WI, this clinical trial (NCT02832245) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Milwaukee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced venous thromboembolism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all venous thromboembolism clinical trials near you to find additional studies recruiting in your area.
See all deep vein thrombosis clinical trials recruiting in Milwaukee — not just this study.
Browse Deep Vein Thrombosis Trials in Milwaukee →